To address whether the human c-MYC protein acts as a rejection antigen, increasing cell numbers of the lymphoma cell line 291PC were injected subcutaneously into wild-type (Figure 1B) and GFP-transgenic mice (Figure 1C). This evidence concerns the gene MYC and lymphoma.